Literature DB >> 32986966

Syncytium cell growth increases Kir2.1 contribution in human iPSC-cardiomyocytes.

Weizhen Li1, Julie L Han1, Emilia Entcheva1.   

Abstract

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) enable cardiotoxicity testing and personalized medicine. However, their maturity is of concern, including relatively depolarized resting membrane potential and more spontaneous activity compared with adult cardiomyocytes, implicating low or lacking inward rectifier potassium current (Ik1). Here, protein quantification confirms Kir2.1 expression in hiPSC-CM syncytia, albeit several times lower than in adult heart tissue. We find that hiPSC-CM culture density influences Kir2.1 expression at the mRNA level (potassium inwardly rectifying channel subfamily J member 2) and at the protein level and its associated electrophysiology phenotype. Namely, all-optical cardiac electrophysiology and pharmacological treatments reveal reduction of spontaneous and irregular activity and increase in action potential upstroke in denser cultures. Blocking Ik1-like currents with BaCl2 increased spontaneous frequency and blunted action potential upstrokes during pacing in a dose-dependent manner only in the highest-density cultures, in line with Ik1's role in regulating the resting membrane potential. Our results emphasize the importance of syncytial growth of hiPSC-CMs for more physiologically relevant phenotype and the power of all-optical electrophysiology to study cardiomyocytes in their multicellular setting.NEW & NOTEWORTHY We identify cell culture density and cell-cell contact as an important factor in determining the expression of a key ion channel at the transcriptional and the protein levels, KCNJ2/Kir2.1, and its contribution to the electrophysiology of human induced pluripotent stem cell-derived cardiomyocytes. Our results indicate that studies on isolated cells, out of tissue context, may underestimate the cellular ion channel properties being characterized.

Entities:  

Keywords:  Ik1; Kir2.1; all-optical electrophysiology; cardiac electrophysiology; cell density; human iPSC-cardiomyocytes; maturity; optogenetics

Mesh:

Substances:

Year:  2020        PMID: 32986966      PMCID: PMC7789971          DOI: 10.1152/ajpheart.00148.2020

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  47 in total

1.  Developmental increases in the inwardly rectifying potassium current of rat ventricular myocytes.

Authors:  G M Wahler
Journal:  Am J Physiol       Date:  1992-05

2.  Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs.

Authors:  Min Li; Yasunari Kanda; Takashi Ashihara; Tetsuo Sasano; Yuji Nakai; Masami Kodama; Erina Hayashi; Yuko Sekino; Tetsushi Furukawa; Junko Kurokawa
Journal:  J Pharmacol Sci       Date:  2017-05-27       Impact factor: 3.337

3.  Determinants of electrical activity in clusters of cultured cardiac cells from neonatal rats.

Authors:  O F Schanne; E Ruiz-Ceretti; C Rivard; D Chartier
Journal:  J Mol Cell Cardiol       Date:  1977-04       Impact factor: 5.000

4.  Electronic "expression" of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells.

Authors:  Glenna C L Bett; Aaron D Kaplan; Agnieszka Lis; Thomas R Cimato; Emmanuel S Tzanakakis; Qinlian Zhou; Michael J Morales; Randall L Rasmusson
Journal:  Heart Rhythm       Date:  2013-09-19       Impact factor: 6.343

5.  Multimodal on-axis platform for all-optical electrophysiology with near-infrared probes in human stem-cell-derived cardiomyocytes.

Authors:  Aleksandra Klimas; Gloria Ortiz; Steven C Boggess; Evan W Miller; Emilia Entcheva
Journal:  Prog Biophys Mol Biol       Date:  2019-03-05       Impact factor: 3.667

6.  Inwardly rectifying potassium current in rat fetal and neonatal ventricular cardiomyocytes.

Authors:  H Masuda; N Sperelakis
Journal:  Am J Physiol       Date:  1993-10

7.  Changes in action potentials and ion currents in long-term cultured neonatal rat ventricular cells.

Authors:  W Guo; K Kamiya; J Cheng; J Toyama
Journal:  Am J Physiol       Date:  1996-07

Review 8.  Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems.

Authors:  Tarek Magdy; Adam J T Schuldt; Joseph C Wu; Daniel Bernstein; Paul W Burridge
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-10-06       Impact factor: 13.820

9.  Maximum diastolic potential of human induced pluripotent stem cell-derived cardiomyocytes depends critically on I(Kr).

Authors:  Michael Xavier Doss; José M Di Diego; Robert J Goodrow; Yuesheng Wu; Jonathan M Cordeiro; Vladislav V Nesterenko; Héctor Barajas-Martínez; Dan Hu; Janire Urrutia; Mayurika Desai; Jacqueline A Treat; Agapios Sachinidis; Charles Antzelevitch
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

10.  hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia Screen.

Authors:  André Monteiro da Rocha; Katherine Campbell; Sergey Mironov; Jiang Jiang; Lakshmi Mundada; Guadalupe Guerrero-Serna; José Jalife; Todd J Herron
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

View more
  6 in total

Review 1.  Cardiac optogenetics: a decade of enlightenment.

Authors:  Emilia Entcheva; Matthew W Kay
Journal:  Nat Rev Cardiol       Date:  2020-12-18       Impact factor: 32.419

2.  Protein and mRNA Quantification in Small Samples of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes in 96-Well Microplates.

Authors:  Weizhen Li; Julie L Han; Emilia Entcheva
Journal:  Methods Mol Biol       Date:  2022

3.  Optogenetic current in myofibroblasts acutely alters electrophysiology and conduction of co-cultured cardiomyocytes.

Authors:  Geran M Kostecki; Yu Shi; Christopher S Chen; Daniel H Reich; Emilia Entcheva; Leslie Tung
Journal:  Sci Rep       Date:  2021-02-24       Impact factor: 4.379

Review 4.  Challenges and innovation: Disease modeling using human-induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Louise Reilly; Saba Munawar; Jianhua Zhang; Wendy C Crone; Lee L Eckhardt
Journal:  Front Cardiovasc Med       Date:  2022-08-12

5.  Integration of Engineered "Spark-Cell" Spheroids for Optical Pacing of Cardiac Tissue.

Authors:  Christianne J Chua; Julie L Han; Weizhen Li; Wei Liu; Emilia Entcheva
Journal:  Front Bioeng Biotechnol       Date:  2021-06-18

Review 6.  Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology.

Authors:  Maria R Pozo; Gantt W Meredith; Emilia Entcheva
Journal:  Cells       Date:  2022-01-07       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.